|
|
||||||||
The Journal of Immunology, Vol 156, Issue 5 1764-1771, Copyright © 1996 by American Association of Immunologists
ARTICLES |
DL Mueller, S Seiffert, W Fang and TW Behrens
Department of Medicine, Center for Immunology, University of Minnesota Medical School, Minneapolis 55455, USA.
In this study, we examined the molecular signals that control apoptosis in cloned CD4+ helper T cells. Resting T cells were highly resistant to spontaneous death in the absence of exogenous stress, and they expressed low levels of bcl-x protein and no detectable bcl-2. Upon exposure to gamma radiation, resting cells rapidly underwent apoptotic death. Incubation with IL-2 prevented this cell death and led to a large increase in bcl-2 protein expression and only a modest up- regulation in bcl-x. The combination of anti-CD3 and anti-CD28 mAbs was also effective in protecting the cells against radiation-induced apoptosis; however, this protection was associated predominantly with bcl-x up-regulation, and only a small induction of bcl-2 protein was observed. Finally, cyclosporin A blocked both IL-2 secretion and bcl-2 induction in response to CD3 plus CD28 stimulation, suggesting a role for endogenous lymphokine production in the induction of bcl-2. These data support a model in which memory T cells remain resistant to apoptosis because intermittent contact with Ag-bearing APC and IL-2R occupancy result in the expression of the life-proteins bcl-2 and bcl-x.
This article has been cited by other articles:
![]() |
J. O. Valenzuela, C. D. Hammerbeck, and M. F. Mescher Cutting Edge: Bcl-3 Up-Regulation by Signal 3 Cytokine (IL-12) Prolongs Survival of Antigen-Activated CD8 T Cells J. Immunol., January 15, 2005; 174(2): 600 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Gelman, J. Zhang, Y. Choi, and L. A. Turka Toll-Like Receptor Ligands Directly Promote Activated CD4+ T Cell Survival J. Immunol., May 15, 2004; 172(10): 6065 - 6073. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Canto, J. L. Rodriguez-Sanchez, and S. Vidal Distinctive response of naive lymphocytes from cord blood to primary activation via TCR J. Leukoc. Biol., December 1, 2003; 74(6): 998 - 1007. [Abstract] [Full Text] |
||||
![]() |
A. Castilleja, D. Carter, C. L. Efferson, N. E. Ward, K. Kawano, B. Fisk, A. P. Kudelka, D. M. Gershenson, J. L. Murray, C. A. O'Brian, et al. Induction of Tumor-Reactive CTL by C-Side Chain Variants of the CTL Epitope HER-2/neu Protooncogene (369-377) Selected by Molecular Modeling of the Peptide: HLA-A2 Complex J. Immunol., October 1, 2002; 169(7): 3545 - 3554. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nguyen and B. C. Miller CD28 Costimulation Induces {delta} Opioid Receptor Expression During Anti-CD3 Activation of T Cells J. Immunol., May 1, 2002; 168(9): 4440 - 4445. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. Chuang, S. Morefield, C.-Y. Liu, S. Chen, J. M. Harlan, and D. M. Willerford Perturbation of B-cell development in mice overexpressing the Bcl-2 homolog A1 Blood, May 1, 2002; 99(9): 3350 - 3359. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hombach, A. Wieczarkowiecz, T. Marquardt, C. Heuser, L. Usai, C. Pohl, B. Seliger, and H. Abken Tumor-Specific T Cell Activation by Recombinant Immunoreceptors: CD3{zeta} Signaling and CD28 Costimulation Are Simultaneously Required for Efficient IL-2 Secretion and Can Be Integrated Into One Combined CD28/CD3{zeta} Signaling Receptor Molecule J. Immunol., December 1, 2001; 167(11): 6123 - 6131. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rebollo, V. Ayllon, A. Fleischer, C. Martinez-A., and A. Zaballos The Association of Aiolos Transcription Factor and Bcl-xL Is Involved in the Control of Apoptosis J. Immunol., December 1, 2001; 167(11): 6366 - 6373. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. d. C. Bittencourt, S. Perruche, E. Contassot, S. Fresnay, M.-H. Baron, R. Angonin, F. Aubin, P. Herve, P. Tiberghien, and P. Saas Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers Blood, July 1, 2001; 98(1): 224 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Grayson, A. J. Zajac, J. D. Altman, and R. Ahmed Cutting Edge: Increased Expression of Bcl-2 in Antigen-Specific Memory CD8+ T Cells J. Immunol., April 15, 2000; 164(8): 3950 - 3954. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Jenks and J. Miller Inhibition of IL-4 Responses After T Cell Priming in the Context of LFA-1 Costimulation Is Not Reversed by Restimulation in the Presence of CD28 Costimulation J. Immunol., January 1, 2000; 164(1): 72 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Thomis, J. Aramburu, and L. J. Berg The Jak Family Tyrosine Kinase Jak3 Is Required for IL-2 Synthesis by Naive/Resting CD4+ T Cells J. Immunol., November 15, 1999; 163(10): 5411 - 5417. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. G. Sechler, S. A. Hansal, D. I. Morris, H. I. McFarland, and A. S. Rosenberg Antigen Presentation Determines the Fate of the T Memory Response In Vivo After Sublethal Gamma-Irradiation J. Immunol., November 1, 1999; 163(9): 4701 - 4706. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Krummel, W. R. Heath, and J. Allison Differential Coupling of Second Signals for Cytotoxicity and Proliferation in CD8+ T Cell Effectors: Amplification of the Lytic Potential by B7 J. Immunol., September 15, 1999; 163(6): 2999 - 3006. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hong, M.-D. Lai, Y.-S. Lin, and M.-Z. Lai Antagonism of p53-dependent Apoptosis by Mitogen Signals Cancer Res., June 1, 1999; 59(12): 2847 - 2852. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mitchell, J. Kappler, and P. Marrack Bystander Virus Infection Prolongs Activated T Cell Survival J. Immunol., April 15, 1999; 162(8): 4527 - 4535. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Marrack, J. Kappler, and T. Mitchell Type I Interferons Keep Activated T Cells Alive J. Exp. Med., February 1, 1999; 189(3): 521 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-N. Malvey, M. K. Jenkins, and D. L. Mueller Peripheral Immune Tolerance Blocks Clonal Expansion but Fails to Prevent the Differentiation of Th1 Cells J. Immunol., September 1, 1998; 161(5): 2168 - 2177. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Collette, A. Benziane, D. Razanajaona, and D. Olive Distinct Regulation of T-Cell Death by CD28 Depending on Both Its Aggregation and T-Cell Receptor Triggering: A Role for Fas-FasL Blood, August 15, 1998; 92(4): 1350 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schirmer, A. N. Vallejo, C. M. Weyand, and J. J. Goronzy Resistance to Apoptosis and Elevated Expression of Bcl-2 in Clonally Expanded CD4+CD28- T Cells from Rheumatoid Arthritis Patients J. Immunol., July 15, 1998; 161(2): 1018 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Zuckerman, L. Pullen, and J. Miller Functional Consequences of Costimulation by ICAM-1 on IL-2 Gene Expression and T Cell Activation J. Immunol., April 1, 1998; 160(7): 3259 - 3268. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Druilhe, M. Arock, L. Le Goff, and M. Pretolani Human Eosinophils Express Bcl-2 Family Proteins: Modulation of Mcl-1 Expression by IFN-gamma Am. J. Respir. Cell Mol. Biol., March 1, 1998; 18(3): 315 - 322. [Abstract] [Full Text] |
||||
![]() |
F. Hashimoto, N. Oyaizu, V. S. Kalyanaraman, and S. Pahwa Modulation of Bcl-2 Protein by CD4 Cross-Linking: A Possible Mechanism for Lymphocyte Apoptosis in Human Immunodeficiency Virus Infection and for Rescue of Apoptosis by Interleukin-2 Blood, July 15, 1997; 90(2): 745 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Rodeck, M. Jost, J. DuHadaway, C. Kari, P. J. Jensen, B. Risse, and D. L. Ewert Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor PNAS, May 13, 1997; 94(10): 5067 - 5072. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |